WOOF:NSD-Pet Acquisition LLC (USD)

COMMON STOCK | Other |

Last Closing

USD 4.65

Change

-0.27 (-5.49)%

Market Cap

USD 7.56B

Volume

3.75M

Analyst Target

USD 87.33
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates in two segments, Animal Hospital and Laboratory. The Animal Hospital segment offers general medical and surgical services for companion animals, as well as specialized treatments comprising diagnostic, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology services; and sells related retail and pharmaceutical products. It also provides specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and additional services, such as grooming, bathing, and boarding services. In addition, this segment performs various pet wellness programs, such as health examinations, diagnostic testing, routine vaccinations, spaying, neutering, and dental care. As of December 31, 2016, it operated or managed 795 animal hospitals. The Laboratory segment offers testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment, and prevention of diseases and other conditions affecting animals. This segment serves animal hospitals, animal practices, universities, and other government organizations. It operated a network of 61 veterinary diagnostic laboratories. VCA Inc. also sells digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market, as well as provides education and training, consulting, and mobile imaging services; and franchises pet services, including dog day care, overnight boarding, grooming, and other ancillary services at pet care facilities. The company was formerly known as VCA Antech, Inc. and changed its name to VCA Inc. in June 2014. VCA Inc. was founded in 1986 and is headquartered in Los Angeles, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
JSM Navient Corporation SR NT 6% 1..

-0.09 (-0.44%)

USD 5.60B
BHFAL Brighthouse Financial Inc

-0.05 (-0.20%)

USD 5.03B
RGC Regencell Bioscience Holdings ..

-0.39 (-5.65%)

USD 3.60B
OB Outbrain Inc

+0.05 (+1.08%)

USD 1.71B
RILYG B. Riley Financial Inc. 5.00% ..

+0.38 (+2.84%)

USD 0.54B
RILYZ B. Riley Financial Inc. 5.25% ..

+0.21 (+2.11%)

USD 0.54B
NEWTZ Newtek Business Services Corp...

+0.02 (+0.08%)

USD 0.45B
NEWTI NewtekOne, Inc. 8.00% Fixed Ra..

+0.06 (+0.24%)

USD 0.43B
GAINN Gladstone Investment Corporati..

+0.43 (+1.71%)

USD 0.39B
RELY Remitly Global Inc

-0.05 (-0.35%)

USD 0.37B

ETFs Containing WOOF

KATZ:XETRA 0.00 % 0.00 %

N/A

N/A
PETZ:LSE 0.00 % 0.00 %

N/A

N/A
PETZ:SW 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 47.15% 97% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.15% 97% N/A 90% A-
Trailing 12 Months  
Capital Gain 16.54% 87% B+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.54% 79% B- 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -35.84% 8% B- 7% C-
Dividend Return -35.84% 8% B- 7% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 27.71% 51% F 65% D
Risk Adjusted Return -129.34% 5% F 1% F
Market Capitalization 7.56B 100% F 91% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.